Literature DB >> 11378187

Short-term penicillin-V prophylaxis did not prevent acute otitis media in infants.

M Foglé-Hansson1, P White, A Hermansson, K Prellner.   

Abstract

OBJECTIVE: To determine whether prophylactic, short-term penicillin V treatment during upper respiratory tract infections can prevent the occurrence of recurrent acute otitis media in young children.
METHODS: Seventy children were studied in a prospective, double-blind, placebo-controlled study. All children had suffered their first episode of acute otitis media before the age of 6 months. After inclusion in the study group, administration of penicillin V or placebo was initiated by the parents at subsequent upper respiratory tract infections. The children were examined by otomicroscopy within 3 days after treatment was initiated. The children were scheduled for a total follow-up period of 12 months, including bimonthly visits for check-up irrespective of treatment periods.
RESULTS: There were 304 treated episodes of upper respiratory tract infection. There was no significant difference in the number of acute otitis episodes between groups.
CONCLUSION: Initiation of penicillin V prophylaxis at upper respiratory tract infection in small children did not prevent recurrent acute otitis media in this study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11378187     DOI: 10.1016/s0165-5876(01)00477-3

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  2 in total

1.  Amoxicillin/clavulanic acid is ineffective at preventing otitis media in children with presumed viral upper respiratory infection: a randomized, double-blind equivalence, placebo-controlled trial.

Authors:  Elisabeth Autret-Leca; Bruno Giraudeau; Marie Joseph Ployet; Annie-Pierre Jonville-Béra
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 2.  Prevention of otitis media caused by viral upper respiratory tract infection: vaccines, antivirals, and other approaches.

Authors:  William J Doyle; Cuneyt M Alper
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.